Milestone Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIST and other ETFs, options, and stocks.About MIST
Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients.
MIST Key Statistics
Stock Snapshot
Milestone Pharmaceuticals(MIST) stock is priced at $2.13, giving the company a market capitalization of 182.69M. It carries a P/E multiple of -2.49.
On 2025-12-20, Milestone Pharmaceuticals(MIST) stock traded between a low of $2.02 and a high of $2.20. Shares are currently priced at $2.13, which is +5.4% above the low and -3.1% below the high.
The Milestone Pharmaceuticals(MIST)'s current trading volume is 5.84M, compared to an average daily volume of 15.73M.
In the last year, Milestone Pharmaceuticals(MIST) shares hit a 52-week high of $3.06 and a 52-week low of $0.63.
In the last year, Milestone Pharmaceuticals(MIST) shares hit a 52-week high of $3.06 and a 52-week low of $0.63.
MIST News
Milestone Pharmaceuticals (MIST) announced that the U.S. Food and Drug Administration, FDA, approved its first commercial product, CARDAMYST nasal spray, a pres...